Youmansʼ Neurological Surgery

Walter W. Whisler

Clinical Neuropharmacology

Neurological DisorderSurgeryNeurologyYoumansʼ Neurological SurgeryNeurorehabilitation +4

The Nighttime Problems of Parkinsonʼs Disease

Andrew J. Lees, N. A. Blackburn, Vivien L. Campbell

Clinical Neuropharmacology

Sleep DisordersSleepParkinsonʼs DiseaseSleep DisorderPsychiatry +12

Falls and Parkinsonʼs Disease

William C. Roller, Sander L. Glatt, Bridget Vetere-Overfield, +1

Clinical Neuropharmacology

A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia

Robert A. Hauser, Jeffrey Friedlander, Theresa Zesiewicz, +5

Clinical Neuropharmacology

Neurological FunctioningKinesiologyNeurological DisorderParkinson DiseaseHome Diary +13

A “Glutamatergic Hypothesis” of Schizophrenia

Stephen I. Deutsch, John Mastropaolo, Barbara L. Schwartz, +2

Clinical Neuropharmacology

Barbara L.Literary TheoryLiterary HistoryLiterary StudyComparative Literature +12

Sleep Disruption in the Course of Chronic Levodopa Therapy

Paul A. Nausieda, William J. Weiner, Linda R. Kaplan, +2

Clinical Neuropharmacology

Optimizing Levodopa Pharmacokinetics: Intestinal Infusion Versus Oral Sustained-Release Tablets

Dag Nyholm, Håkan Askmark, Cecilia Gomes–Trolin, +4

Clinical Neuropharmacology

Levodopa PharmacokineticsMedicineParkinson DiseaseClinical PharmacologyPharmacotherapy +6

Assessment of Parkinsonʼs Disease

Thomas Larsen, Susan Calne, Donald B. Calne

Clinical Neuropharmacology

NeuropsychologyMotor DysfunctionNeurological DisorderCorticobasal DegenerationClinical Neurology +20

Efficacy and Tolerability of Blonanserin in the Patients With Schizophrenia

Jae-Won Yang, Won‐Myong Bahk, Hyun Sang Cho, +13

Clinical Neuropharmacology

Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers

Eric Siemers, Michael Skinner, Robert A. Dean, +5

Clinical Neuropharmacology